David M. Nathan

26.5k total citations · 10 hit papers
124 papers, 17.1k citations indexed

About

David M. Nathan is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, David M. Nathan has authored 124 papers receiving a total of 17.1k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Endocrinology, Diabetes and Metabolism, 42 papers in Genetics and 25 papers in Surgery. Recurrent topics in David M. Nathan's work include Diabetes Management and Research (97 papers), Diabetes Treatment and Management (50 papers) and Diabetes and associated disorders (41 papers). David M. Nathan is often cited by papers focused on Diabetes Management and Research (97 papers), Diabetes Treatment and Management (50 papers) and Diabetes and associated disorders (41 papers). David M. Nathan collaborates with scholars based in United States, Australia and Canada. David M. Nathan's co-authors include John M. Lachin, Daniel E. Singer, James B. Meigs, Peter W.F. Wilson, Ralph B. D’Agostino, J.C. Kuenen, Rikke Borg, Robert J. Heine, David Schoenfeld and Hui Zheng and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

David M. Nathan

121 papers receiving 16.2k citations

Hit Papers

Intensive Diabetes Treatment and Cardiovasc... 1984 2026 1998 2012 2005 2013 2008 2006 2011 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
    2005 3.6k citations David M. Nathan profile →
  2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
    2013 1.3k citations David M. Nathan Diabetes Care profile →
  3. Translating the A1C Assay Into Estimated Average Glucose Values
    2008 1.2k citations David M. Nathan, David Schoenfeld et al. Diabetes Care profile →
  4. Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
    2006 820 citations David M. Nathan et al. profile →
  5. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
    2011 710 citations David B. Sacks, Mark A. Arnold et al. profile →
  6. The Clinical Information Value of the Glycosylated Hemoglobin Assay
    1984 546 citations David M. Nathan, Daniel E. Singer et al. profile →
  7. Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
    2014 406 citations David M. Nathan et al. profile →
  8. Diabetes
    2015 306 citations David M. Nathan JAMA profile →
  9. Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality
    2015 303 citations Trevor J. Orchard, David M. Nathan et al. JAMA profile →
  10. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
    2023 116 citations David B. Sacks, Mark A. Arnold et al. Diabetes Care profile →

Peers

David M. Nathan
Robert E. Ratner United States
Irl B. Hirsch United States
Michel Marre France
Janet B. McGill United States
Carol Forsblom Finland
Helen M. Colhoun United Kingdom
Mark E. Molitch United States
Per‐Henrik Groop Finland
H. A. W. Neil United Kingdom
Simon Heller United Kingdom
Robert E. Ratner United States
David M. Nathan
Citations per year, relative to David M. Nathan David M. Nathan (= 1×) peers Robert E. Ratner

Countries citing papers authored by David M. Nathan

Since Specialization
Citations

This map shows the geographic impact of David M. Nathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Nathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Nathan more than expected).

Fields of papers citing papers by David M. Nathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Nathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Nathan. The network helps show where David M. Nathan may publish in the future.

Co-authorship network of co-authors of David M. Nathan

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Nathan. A scholar is included among the top collaborators of David M. Nathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Nathan. David M. Nathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knowler, William C., Sharon L. Edelstein, Peter H. Bennett, et al.. (2025). Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial. The Lancet Diabetes & Endocrinology. 13(6). 469–481. 3 indexed citations
2.
Sacks, David B., Mark A. Arnold, George L. Bakris, et al.. (2023). Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes Care. 46(10). e151–e199. 116 indexed citations breakdown →
3.
Sacks, David B., Mark A. Arnold, George L. Bakris, et al.. (2023). Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes Care. 46(10). 1740–1746. 11 indexed citations
4.
Bebu, Ionut, Sareh Keshavarzi, Xiaoyu Gao, et al.. (2021). Genetic Risk Factors for CVD in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care. 44(6). 1309–1316. 8 indexed citations
5.
Bebu, Ionut, Barbara H. Braffett, Trevor J. Orchard, et al.. (2020). Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT/EDIC study. Diabetes Research and Clinical Practice. 171. 108591–108591. 10 indexed citations
6.
Orchard, Trevor J., David M. Nathan, Bernard Zinman, et al.. (2015). Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality. JAMA. 313(1). 45–45. 303 indexed citations breakdown →
7.
Weinstock, Ruth S., Sonia Caprio, Kenneth C. Copeland, et al.. (2013). Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: The TODAY clinical trial.. Diabetes Care. 84 indexed citations
8.
Nathan, David M., Paula McGee, Michael W. Steffes, & John M. Lachin. (2013). Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study. Diabetes. 63(1). 282–290. 176 indexed citations
9.
Nathan, David M., John B. Buse, Steven E. Kahn, et al.. (2013). Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care. 36(8). 2254–2261. 174 indexed citations
10.
Shimizu, Tomoaki, David M. Nathan, John B. Buse, et al.. (2012). [Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes].. PubMed. 70 Suppl 3. 591–601. 10 indexed citations
11.
Faustman, Denise L., Limei Wang, Yoshiaki Okubo, et al.. (2012). Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes. PLoS ONE. 7(8). e41756–e41756. 112 indexed citations
12.
Zheng, Hui, David M. Nathan, & David Schoenfeld. (2011). Using A Multi-Level B-Spline Model to Analyze and Compare Patient Glucose Profiles Based on Continuous Monitoring Data. Diabetes Technology & Therapeutics. 13(6). 675–682. 9 indexed citations
13.
Türkbey, Evrim, Jye‐Yu C. Backlund, Saul Genuth, et al.. (2011). Myocardial Structure, Function, and Scar in Patients With Type 1 Diabetes Mellitus. Circulation. 124(16). 1737–1746. 72 indexed citations
14.
Delahanty, Linda M., David M. Nathan, John M. Lachin, et al.. (2008). Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial. American Journal of Clinical Nutrition. 89(2). 518–524. 108 indexed citations
15.
Ginde, Adit A., Enrico Cagliero, David M. Nathan, & Carlos A. Camargo. (2008). Point‐of‐care Glucose and Hemoglobin A1c in Emergency Department Patients without Known Diabetes: Implications for Opportunistic Screening. Academic Emergency Medicine. 15(12). 1241–1247. 33 indexed citations
16.
17.
Miljanović, Biljana, Robert J. Glynn, David M. Nathan, JoAnn E. Manson, & Debra A. Schaumberg. (2003). Serum Lipid Levels and Diabetic Retinopathy in Type 1 Diabetes Mellitus. Investigative Ophthalmology & Visual Science. 44(13). 3099–3099.
18.
Nathan, David M., et al.. (1996). Glycemic control in diabetes mellitus: have changes in therapy made a difference?. The American Journal of Medicine. 100(2). 157–163. 67 indexed citations
19.
Lewandrowski, Kent, Robert Cheek, David M. Nathan, et al.. (1992). Implementation of capillary blood glucose monitoring in a teaching hospital and determination of program requirements to maintain quality testing. The American Journal of Medicine. 93(4). 419–426. 42 indexed citations
20.
Nathan, David M.. (1988). Modern Management of Insulin-dependent Diabetes Mellitus. Medical Clinics of North America. 72(6). 1365–1378. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert E. Ratner Breakdown of academic impact, for papers by Irl B. Hirsch Breakdown of academic impact, for papers by Michel Marre Breakdown of academic impact, for papers by Janet B. McGill Breakdown of academic impact, for papers by Carol Forsblom Breakdown of academic impact, for papers by Helen M. Colhoun Breakdown of academic impact, for papers by Mark E. Molitch Breakdown of academic impact, for papers by Per‐Henrik Groop Breakdown of academic impact, for papers by H. A. W. Neil Breakdown of academic impact, for papers by Simon Heller
Rankless by CCL
2026